This report contains certain estimates and forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and
Section 27A of the Securities Act of 1933, as amended, which are intended to be
covered by the safe harbor provisions for forward-looking statements contained
in the Private Securities Litigation Reform Act of 1995, and may be identified
by their use of words like "plans," "expects," "will," "anticipates,"
"believes," "intends," "projects," "estimates," "outlook," or other words of
similar meaning. All statements that address expectations or projections about
the future, including statements about Corteva's strategy for growth, product
development, regulatory approval, market position, liquidity, anticipated
benefits of recent acquisitions, timing of anticipated benefits from
restructuring actions, outcome of contingencies, such as litigation and
environmental matters, expenditures, and financial results, as well as its
expectations related to its separation of Corteva from DowDuPont and the
agreements related thereto, are forward-looking statements.

Forward-looking statements and other estimates are based on certain assumptions
and expectations of future events which may not be accurate or realized.
Forward-looking statements and other estimates also involve risks and
uncertainties, many of which are beyond Corteva's control. While the list of
factors presented below is considered representative, no such list should be
considered to be a complete statement of all potential risks and uncertainties.
Unlisted factors may present significant additional obstacles to the realization
of forward-looking statements. Consequences of material differences in results
as compared with those anticipated in the forward-looking statements could
include, among other things, business disruption, operational problems,
financial loss, legal liability to third parties and similar risks, any of which
could have a material adverse effect on Corteva's business, results of
operations and financial condition. Some of the important factors that could
cause Corteva's actual results to differ materially from those projected in any
such forward-looking statements include: (i) failure to obtain or maintain the
necessary regulatory approvals for some of Corteva's products; (ii) failure to
successfully develop and commercialize Corteva's pipeline; (iii) effect of the
degree of public understanding and acceptance or perceived public acceptance of
Corteva's biotechnology and other agricultural products; (iv) effect of changes
in agricultural and related policies of governments and international
organizations; (v) effect of competition and consolidation in Corteva's
industry; (vi) effect of competition from manufacturers of generic products;
(vii) costs of complying with evolving regulatory requirements and the effect of
actual or alleged violations of environmental laws or permit requirements;
(viii) effect of climate change and unpredictable seasonal and weather factors;
(ix) risks related to oil and commodity markets; (x) competitor's establishment
of an intermediary platform for distribution of Corteva's products; (xi) impact
of Corteva's dependence on third parties with respect to certain of its raw
materials or licenses and commercialization; (xii) effect of industrial
espionage and other disruptions to Corteva's supply chain, information
technology or network systems; (xiii) effect of volatility in Corteva's input
costs; (xiv) failure to realize the anticipated benefits of the internal
reorganizations taken by DowDuPont in connection with the spin-off of Corteva
and other cost savings initiatives; (xv) failure to raise capital through the
capital markets or short-term borrowings on terms acceptable to Corteva; (xvi)
failure of Corteva's customers to pay their debts to Corteva, including customer
financing programs; (xvii) increases in pension and other post-employment
benefit plan funding obligations; (xviii) risks related to the indemnification
obligations of legacy EID liabilities in connection with the separation of
Corteva; (xix) effect of compliance with laws and requirements and adverse
judgments on litigation; (xx) risks related to Corteva's global operations;
(xxi) failure to effectively manage acquisitions, divestitures, alliances and
other portfolio actions; (xxii) risks related to COVID-19; (xxiii) risks related
to activist stockholders; (xxiv) Corteva's intellectual property rights or
defend against intellectual property claims asserted by others; (xxv) effect of
counterfeit products; (xxvi) Corteva's dependence on intellectual property
cross-license agreements; (xxvii) other risks related to the separation from
DowDuPont; (xxviii) risks related to the Biden executive order Promoting
Competition in the American Economy; and (xxix) risks associated with our CEO
transition, including failure to timely identify a successor CEO.

Additionally, there may be other risks and uncertainties that Corteva is unable
to currently identify or that Corteva does not currently expect to have a
material impact on its business. Where, in any forward-looking statement or
other estimate, an expectation or belief as to future results or events is
expressed, such expectation or belief is based on the current plans and
expectations of Corteva's management and expressed in good faith and believed to
have a reasonable basis, but there can be no assurance that the expectation or
belief will result or be achieved or accomplished. Corteva disclaims and does
not undertake any obligation to update or revise any forward-looking statement,
except as required by applicable law. A detailed discussion of some of the
significant risks and uncertainties which may cause results and events to differ
materially from such forward-looking statements or other estimates is included
in the "Risk Factors" section of Corteva's 2020 Annual Report, as modified by
subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.



                                       42
--------------------------------------------------------------------------------
  Table of Contents
Recent Developments

COVID-19 Pandemic
On March 11, 2020, the World Health Organization ("WHO") declared the novel
coronavirus disease ("COVID-19") a pandemic. The global health crisis caused by
COVID-19 and the related government actions and stay at home orders have
negatively impacted economic activity and increased political instability across
the globe. Since the crisis began Corteva has engaged its global Integrated
Health Services Pandemic & Infectious Disease Team to take actions and implement
guidelines and protocols in response to the COVID-19 pandemic described in its
2020 Annual Report, Part II, Item 7. Management's Discussion and Analysis of
Financial Condition and Results of Operations, COVID-19 Pandemic.

When COVID-19 is demonstrably contained, the company anticipates a rebound in
economic activity, depending on the rate, pace, and effectiveness of the
containment efforts deployed by various national, state, and local governments,
vaccination rates, and the ability of COVD-19 variants to overcome containment
efforts, available vaccines, and medical treatments. Corteva will continue to
actively monitor the situation and may take further actions altering its
business operations that it determines are in the best interests of its
stakeholders, or as required by federal, state, or local authorities. It is not
clear what the potential effects any such alterations or modifications may have
on the company's business, including the effects on its customers, employees,
and prospects, or on its financial results for 2021 and beyond. With the ongoing
volatility in global markets, the company will continue to monitor various
factors that could impact earnings and cash flows of the business, including,
but not limited to the inflation of, or unavailability of raw material inputs
and transportation and logistics services, currency fluctuations, expectations
of future planted area (as influenced by consumer demand, ethanol markets and
government policies and regulations), trade and purchasing of commodities
globally and relative commodity prices.

2021 Restructuring Actions
On February 1, 2021, Corteva approved restructuring actions designed to
right-size and optimize footprint and organizational structure according to the
business needs in each region with the focus on driving continued cost
improvement and productivity. As a result of these actions, the company expects
to record total pre-tax restructuring charges of approximately $130 million to
$170 million, comprised of approximately $40 million to $50 million of severance
and related benefit costs, $40 million to $60 million of asset related charges,
$10 million to $15 million of asset retirement obligations and $40 million to
$45 million of costs related to contract terminations (contract terminations
includes early lease terminations). Future cash payments related to this charge
are anticipated to be approximately $80 million to $100 million, primarily
related to the payment of severance and related benefits, asset retirement
obligations, and costs related to contract terminations. The restructuring
actions associated with this charge are expected to be substantially complete in
2021.

During the six months ended June 30, 2021, the company recorded pre-tax charges
of $110 million, recognized in restructuring and asset related charges - net in
the company's interim Consolidated Statement of Operations, primarily related to
the payment of severance and related benefits and contract termination charges.

The 2021 Restructuring Actions are expected to contribute to the company's
ongoing cost and productivity improvement efforts through achieving an estimated
$70 million of savings on a run rate basis by 2023. See Note 5 - Restructuring
and Asset Related Charges - Net, to the interim Consolidated Financial
Statements for additional information.

Share Buyback Plan
On August 5, 2021, Corteva, Inc. announced that its Board of Directors
authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s
common stock, par value $0.01 per share, without an expiration date. The timing,
price and volume of purchases will be based on market conditions, relevant
securities laws and other factors.

On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized
a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock,
par value $0.01 per share, without an expiration date. The company expects to
complete the share repurchase program in 2021. The timing, price and volume of
purchases will be based on market conditions, relevant securities laws and other
factors. During the three and six months ended June 30, 2021, the company
purchased and retired 4,324,000 shares and 11,970,000 shares, respectively, in
the open market for a total cost of $200 million and $550 million, respectively.
During the six months ended June 30, 2020, the company purchased and retired
1,865,000 shares in the open market for a total cost of $50 million.
                                       43

--------------------------------------------------------------------------------

Table of Contents

Overview

The following is a summary of results from continuing operations for the three months ended June 30, 2021:

•The company reported net sales of $5,627 million, up 8 percent versus the same quarter last year, reflecting a 5 percent increase in volume, a 2 percent favorable impact from currency and a 1 percent increase in price.



•Cost of goods sold ("COGS") totaled $3,010 million in the second quarter of
2021, up from $2,829 million in the second quarter of 2020, primarily driven by
increased volumes and higher input costs, freight and logistics, which are
primarily market-driven, partially offset by ongoing cost and productivity
actions.

•Restructuring and asset related charges - net were $135 million in the second
quarter of 2021, a decrease from $179 million in the second quarter of 2020. The
charges for the three months ended June 30, 2021 primarily relate to $112
million of non-cash accelerated prepaid royalty amortization expense related to
Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits,
and $21 million related to severance and related benefit costs, and asset
related charges associated with 2021 Restructuring Actions.

•The provision for income taxes for the three months ended June 30, 2021 includes net tax benefits of $18 million associated with changes in accruals for certain prior year tax positions in various jurisdictions.

•Income from continuing operations after income taxes was $1,018 million, as compared to $766 million in the same quarter last year.



•Operating EBITDA was $1,461 million for the three months ended June 30, 2021,
up from $1,236 million for the three months ended June 30, 2020 primarily driven
by volume gains and strong price execution, which more than offset cost
headwinds. The company experienced cost headwinds in the quarter including
higher input costs, freight and logistics, which are primarily market-driven,
and higher commission expense. The headwinds are partially offset by the
company's ongoing execution on its productivity programs. Refer to page 56 for
further discussion of the company's Non-GAAP financial measures.

The following is a summary of results from continuing operations for the six months ended June 30, 2021:

•The company reported net sales of $9,805 million, up 7 percent versus the same period last year, reflecting a 4 percent increase in volume and a 2 percent increase in local price and a 1 percent favorable impact from currency.



•COGS totaled $5,430 million in the six months ended 2021, up from $5,098
million in the six months ended 2020, primarily driven by increased volumes and
higher input costs, freight and logistics, which are primarily market-driven,
partially offset by ongoing cost and productivity actions.

•Restructuring and asset related charges - net were $235 million in the six
months ended 2021, a decrease from $249 million in the six months ended 2020.
The charges for the six months ended June 30, 2021 primarily relate to $119
million of non-cash accelerated prepaid royalty amortization expense related to
Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits,
and $110 million relate to severance and related benefit costs and asset related
charges, and contract termination charges associated with 2021 Restructuring
Activities.

•The provision for income taxes for the six months ended June 30, 2021 includes
net tax benefits of $25 million associated with changes in accruals for certain
prior year tax positions in various jurisdictions.

•Income from continuing operations after income taxes was $1,631 million, as compared to $1,047 million in the same period last year.



•Operating EBITDA was $2,365 million, up from $2,030 million for the six months
ended June 30, 2020, primarily driven by strong price execution, volume gains,
and favorable mix, which more than offset cost headwinds. The company
experienced cost headwinds in the quarter, including higher input costs, freight
and logistics, which are primarily market-driven, and higher commission expense.
The headwinds are partially offset by the company's ongoing execution on its
productivity programs. Refer to page 56 for further discussion of the company's
Non-GAAP financial measures.

                                       44
--------------------------------------------------------------------------------
  Table of Contents
In addition to the financial highlights above, the following events occurred
during or subsequent to the six months ended June 30, 2021:

•The company returned approximately $750 million to shareholders during the six months ended June 30, 2021 under its previously announced share repurchase program and through common stock dividends.



•On August 5, 2021, Corteva, Inc. announced that its Board of Directors
authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s
common stock, par value $0.01 per share, without an expiration date. The timing,
price and volume of purchases will be based on market conditions, relevant
securities laws and other factors.
•On July 21, 2021, the company's Board of Directors approved an increase in the
common stock dividend of $0.13 per share to $0.14 per share.
                                       45

--------------------------------------------------------------------------------


  Table of Contents

Selected Financial Data
                                                  Three Months Ended             Six Months Ended
In millions, except per share amounts                  June 30,             

June 30,


                                                 2021            2020           2021           2020
Net sales                                   $      5,627    $     5,191    $     9,805    $     9,147

Cost of goods sold                          $      3,010    $     2,829    $     5,430    $     5,098
Percent of net sales                                  53  %          54  %  

55 % 56 %



Research and development expense            $        293    $       273    $       574    $       553
Percent of net sales                                   5  %           5  %           6  %           6  %

Selling, general and administrative
expenses                                    $        998    $       965    $     1,731    $     1,722
Percent of net sales                                  18  %          19  %          18  %          19  %

Effective tax rate on continuing operations 21.8 % 9.2 %

22.1 % 16.4 %



Income from continuing operations after
income taxes                                $      1,018    $       766

$ 1,631 $ 1,047



Income from continuing operations available
to Corteva common stockholders              $      1,015    $       760

$ 1,625 $ 1,031



Basic earnings per share of common stock
from continuing operations                  $       1.37    $      1.01    $      2.19    $      1.37
Diluted earnings per share of common stock
from continuing operations                  $       1.37    $      1.01    $      2.18    $      1.37


                                       46

--------------------------------------------------------------------------------


  Table of Contents

Results of Operations

Net Sales
Net sales were $5,627 million and $5,191 million for the three months ended June
30, 2021 and 2020, respectively. The increase was primarily driven by a 5
percent increase in volume versus the prior year period. Volume increases were
driven by seasonal timing and increased soybean acres in North America, together
with continued adoption of new technology in both segments. Currency and local
price represented increases of 2 percent and 1 percent, respectively.

                               Three Months Ended
                                    June 30,
                          2021                    2020
                    Net Sales               Net Sales
                  ($ Millions)      %     ($ Millions)      %
Worldwide        $       5,627    100  % $       5,191    100  %
North America1           3,842     68  %         3,566     69  %
EMEA2                      710     13  %           643     12  %
Latin America              588     10  %           515     10  %
Asia Pacific               487      9  %           467      9  %


                                       Q2 2021 vs. Q2 2020                                   Percent Change Due To:
                                        Net Sales Change             Local Price &                                            Portfolio /
$ In millions                           $                 %           Product Mix         Volume           Currency              Other
North America1                 $             276              8  %              -  %             6  %               2  %                  -  %
EMEA2                                         67             10  %              5  %            (1) %               6  %                  -  %
Latin America                                 73             14  %              6  %             5  %               3  %                  -  %
Asia Pacific                                  20              4  %              2  %            (2) %               5  %                 (1) %
Total                          $             436              8  %              1  %             5  %               2  %                  -  %


1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").

Net sales were $9,805 million and $9,147 million for the six months ended June
30, 2021 and 2020, respectively. The increase was primarily driven by a 4
percent increase in volume versus the prior-year period. Gains were driven by
the continued penetration of new products and strong execution globally. Local
price and currency represented increases of 2 percent and 1 percent,
respectively.

                                Six Months Ended
                                    June 30,
                          2021                    2020
                    Net Sales               Net Sales
                  ($ Millions)      %     ($ Millions)      %
Worldwide        $       9,805    100  % $       9,147    100  %
North America1           5,585     57  %         5,331     58  %
EMEA2                    2,312     24  %         2,110     23  %
Latin America            1,106     11  %           949     11  %
Asia Pacific               802      8  %           757      8  %


                                       47

--------------------------------------------------------------------------------


  Table of Contents
                                First Half 2021 vs. First Half
                                             2020                                          Percent Change Due To:
                                       Net Sales Change            Local Price &                                            Portfolio /
$ In millions                          $                %           Product Mix         Volume           Currency              Other
North America1                 $           254              5  %              -  %             4  %               1  %                  -  %
EMEA2                                      202             10  %              4  %             1  %               5  %                  -  %
Latin America                              157             17  %              9  %            14  %              (6) %                  -  %
Asia Pacific                                45              6  %              2  %             1  %               5  %                 (2) %
Total                          $           658              7  %              2  %             4  %               1  %                  -  %


1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").

Cost of Goods Sold
COGS was $3,010 million (53 percent of net sales) and $2,829 million (54 percent
of net sales) for the three months ended June 30, 2021 and 2020, respectively.
The increase was primarily driven by higher input costs, freight and logistics,
which are primarily market-driven, an increase in volumes in both crop
protection and seed and unfavorable currency, offset by ongoing cost and
productivity actions. The market driven trends are expected to continue as
global supply chains and logistics remain constrained across industries.

COGS was $5,430 million (55 percent of net sales) and $5,098 million (56 percent
of net sales) for the six months ended June 30, 2021 and 2020, respectively. The
increase was primarily driven by higher input costs, freight and logistics,
which are primarily market-driven, an increase in volumes in both crop
protection and seed and unfavorable currency. The increases in costs are
partially offset by ongoing cost and productivity actions. The market-driven
trends are expected to continue as global supply chains and logistics remain
constrained across industries.

Research and Development Expense R&D expense was $293 million (5 percent of net sales) and $273 million (5 percent of net sales) for the three months ended June 30, 2021 and 2020, respectively. The increase was primarily driven by increases in variable compensation and unfavorable currency.

R&D expense was $574 million (6 percent of net sales) and $553 million (6 percent of net sales) for the six months ended June 30, 2021 and 2020, respectively. The increase was primarily driven by increases in variable compensation, unfavorable currency and increases in laboratory costs.



Selling, General and Administrative Expenses
SG&A expenses were $998 million (18 percent of net sales) and $965 million (19
percent of net sales) for the three months ended June 30, 2021 and 2020,
respectively. The increase was primarily driven by increases in commission
expense and unfavorable currency, partially offset by lower bad debt expense and
ongoing cost and productivity actions taken to curtail spending.

SG&A expenses were $1,731 million (18 percent of net sales) and $1,722 million
(19 percent of net sales) for the six months ended June 30, 2021 and 2020,
respectively. The increase was primarily driven by higher commission expense,
unfavorable currency, and selling expenses to drive sales, partially offset by
lower bad debt expense, functional spend, and travel expense due to COVID-19
related restrictions put into place late in the first quarter of 2020.

Amortization of Intangibles
Intangible asset amortization was $180 million and $176 million for the three
months ended June 30, 2021 and 2020, respectively, and $363 million and $339
million for the six months ended June 30, 2021 and 2020, respectively. The
increase was primarily driven by amortization of the trade name asset that was
changed from indefinite lived intangible asset to definite lived in the fourth
quarter of 2020. See Note 11 - Other Intangible Assets, to the interim
Consolidated Financial Statements for additional information.
                                       48
--------------------------------------------------------------------------------
  Table of Contents
Restructuring and Asset Related Charges - Net
Restructuring and asset related charges - net were $135 million and $179 million
for the three months ended June 30, 2021 and 2020, respectively. The charges in
the second quarter of 2021 primarily relate to non-cash accelerated prepaid
royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready
2 Xtend® herbicide tolerance traits under the Execute to Win Productivity
Program and severance and related benefit costs, asset related charges, and
contract termination charges associated with 2021 Restructuring Actions. The
charges in the second quarter of 2020 related to non-cash accelerated prepaid
royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready
2 Xtend® herbicide tolerance traits and severance and related benefit costs and
asset related charges under the Execute to Win Productivity Program.

Restructuring and asset related charges - net were $235 million and $249 million
for the six months ended June 30, 2021 and 2020, respectively. The charges in
the first half of 2021 primarily related to non-cash accelerated prepaid royalty
amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2
Xtend® herbicide tolerance traits under the Execute to Win Productivity Program
and severance and related benefit costs, asset related charges, and contract
termination charges associated with 2021 Restructuring Actions. The charges in
the first half of 2020 primarily related to non-cash accelerated prepaid royalty
amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2
Xtend® herbicide tolerance traits and asset related charges and severance and
related benefit costs under the Execute to Win Productivity Program.

See Note 5 - Restructuring and Asset Related Charges, Net, to the interim Consolidated Financial Statements for additional information.



Other Income - Net
Other income - net was $298 million and $89 million for the three months ended
June 30, 2021 and 2020, respectively. The increase was primarily due to an
increase in non-operating pension and other post-employment benefit credit,
driven by the December 2020 OPEB plan amendments as discussed in the 2020 Annual
Report. The increase was partially offset by a net exchange loss during the
three months ended June 30, 2021 compared to a net exchange gain during the
three months ended June 30, 2020.

Other income - net was $635 million and $90 million for the six months ended
June 30, 2021 and 2020, respectively. The increase was primarily due to an
increase in non-operating pension and other post-employment benefit credit,
driven by the December 2020 OPEB plan amendments as discussed in the 2020 Annual
Report. In addition, Other income - net for the six months ended June 30, 2020
includes a $(53) million loss on the sale of the La Porte site.
The company routinely uses forward exchange contracts to offset its net
exposures, by currency denominated monetary assets and liabilities of its
operations. The objective of this program is to maintain an approximately
balanced position in foreign currencies in order to minimize, on an after-tax
basis, the effects of exchange rate changes. The net pre-tax exchange gains and
losses are recorded in other income - net and the related tax impact is recorded
in provision for (benefit from) income taxes on continuing operations in the
interim Consolidated Statement of Operations.

See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements for additional information.



Interest Expense
Interest expense was $7 million and $14 million for the three months ended June
30, 2021 and 2020, respectively, and $14 million and $24 million for the six
months ended June 30, 2021 and 2020, respectively. The change was primarily
driven by lower average commercial paper balances and lower interest rates,
partially offset by higher average long-term borrowings.

Provision for Income Taxes on Continuing Operations
The company's provision for income taxes on continuing operations was $284
million for the three months ended June 30, 2021 on pre-tax income from
continuing operations of $1,302 million, resulting in an effective tax rate of
21.8 percent. The effective tax rate was unfavorably impacted by geographic mix
of earnings. Those unfavorable impacts were partially offset by $18 million of
net tax benefits associated with changes in accruals for certain prior year tax
positions in various jurisdictions, as well as tax benefits related to the
issuance of stock-based compensation.

The company's provision for income taxes on continuing operations was $78
million for the three months ended June 30, 2020 on pre-tax income from
continuing operations of $844 million, resulting in an effective tax rate of 9.2
percent. The effective tax rate was favorably impacted by geographic mix of
earnings, $20 million of net tax benefits associated with changes in accruals
for certain prior year tax positions in various jurisdictions, which includes a
tax benefit of $14 million related to a return to accrual adjustment to reflect
a change in estimate on the impact of a tax law enactment in a foreign
jurisdiction. In addition, during the three months ended June 30, 2020, the
company recognized a tax benefit of $51 million to provision for income
                                       49
--------------------------------------------------------------------------------
  Table of Contents
taxes on continuing operations related to a return to accrual adjustment
associated with an elective change in accounting method for the 2019 tax year
impact of the 2017 Tax Cuts and Jobs Act's ("The Act") foreign tax provisions.
The company's provision for income taxes on continuing operations was $462
million for the six months ended June 30, 2021 on pre-tax income from continuing
operations of $2,093 million, resulting in an effective tax rate of 22.1
percent. The effective tax rate was unfavorably impacted by the tax impact of
certain net exchange losses recognized on the re-measurement of the net monetary
asset positions which were not tax-deductible in their local jurisdictions, as
well as geographic mix of earnings. Those unfavorable impacts were partially
offset by $25 million of net tax benefits associated with changes in accruals
for certain prior year tax positions in various jurisdictions, as well as tax
benefits related to the issuance of stock-based compensation.

The company's provision for income taxes on continuing operations was $205
million for the six months ended June 30, 2020 on pre-tax income from continuing
operations of $1,252 million, resulting in an effective tax rate of 16.4%. The
effective tax rate was favorably impacted by geographic mix of earnings, $18
million of net tax benefits associated with changes in accruals for certain
prior year tax positions in various jurisdictions, which includes a tax benefit
of $14 million related to a return to accrual adjustment to reflect a change in
estimate on the impact of a tax law enactment in a foreign jurisdiction. In
addition, during the six months ended June 30, 2020, the company recognized a
tax benefit of $51 million to provision for income taxes on continuing
operations related to a return to accrual adjustment associated with an elective
change in accounting method for the 2019 tax year impact of the The Act's
foreign tax provisions. The effective tax rate was unfavorably impacted by the
tax impact of certain net exchange losses recognized on the re-measurement of
the net monetary asset positions which were not tax-deductible in their local
jurisdictions, as well as tax charges related to the issuance of stock-based
compensation.

(Loss) Income from Discontinued Operations After Tax
(Loss) income from discontinued operations after tax was $(45) million and $(55)
million for the three and six months ended June 30, 2021, respectively, and $0
million and $1 million for the three and six months ended June 30, 2020. The
three and six months ended June 30, 2021 primarily reflects charges relating to
PFAS environmental remediation activities for legacy operations at the
Fayetteville Works facility and the settlement with the State of Delaware for
PFAS related natural resource damage claims. Refer to Note 3 - Divestitures and
Other Transactions, to the interim Consolidated Financial Statements for
additional information.

EID Analysis of Operations
As discussed in Note 1 - Basis of Presentation, to the EID interim Consolidated
Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a
reporting company, subject to the requirements of the Exchange Act. The below
relates to EID only and is presented to provide an Analysis of Operations, only
for the differences between EID and Corteva, Inc.

Interest Expense
EID's interest expense was $20 million and $45 million for the three months
ended June 30, 2021, respectively, and $42 million and $87 million for the six
months ended June 30, 2021 and 2020, respectively. The change was primarily
driven by the items noted on page 49, under the header "Interest Expense," and
by lower average borrowings on the related party loan between EID and Corteva,
Inc. See Note 2 - Related Party Transactions, to the EID interim Consolidated
Financial Statements for further information.

Provision for Income Taxes on Continuing Operations
EID's provision for income taxes on continuing operations was $281 million for
the three months ended June 30, 2021 on pre-tax income from continuing
operations of $1,289 million, resulting in an effective tax rate of 21.8
percent. EID's provision for income taxes on continuing operations was
$71 million for the three months ended June 30, 2020 on pre-tax income from
continuing operations of $813 million, resulting in an effective tax rate of 8.7
percent.

EID's provision for income taxes on continuing operations was $455 million for
the six months ended June 30, 2021 on pre-tax income from continuing operations
of $2,065 million, resulting in an effective tax rate of 22.0 percent. EID's
provision for income taxes on continuing operations was $190 million for the six
months ended June 30, 2020 on pre-tax income from continuing operations of
$1,189 million, resulting in an effective tax rate of 16.0 percent.

EID's effective tax rates for the three and six months ended June 30, 2021 and
2020 were driven by the items noted on page 49, under the header "Provision for
Income Taxes on Continuing Operations" and a tax benefit related to the interest
expense incurred on the related party loan between EID and Corteva, Inc. See
Note 2 - Related Party Transactions, to the EID interim Consolidated Financial
Statements for further information.

                                       50

--------------------------------------------------------------------------------

Table of Contents



Corporate Outlook
The company is increasing its net sales outlook for 2021 and expects an
approximate 7 - 8 percent increase in net sales. Additionally, the company is
increasing earnings expectations for 2021 and expects an increase in Operating
EBITDA and Operating Earnings Per Share of 20 - 25 percent and 33 - 40 percent,
respectively.

Corteva is not able to reconcile its forward-looking non-GAAP financial measures
to its most comparable U.S. GAAP financial measures, as it is unable to predict
with reasonable certainty items outside of the company's control, such as
Significant Items, without unreasonable effort (refer to page 57 for Significant
Items recorded in the three and six months ended June 30, 2021 and 2020). During
2021, the company expects to record $130 million to $170 million for the 2021
Restructuring Actions and approximately $130 million for non-cash accelerated
prepaid royalty amortization expense as restructuring and asset related charges.
See Note 5 - Restructuring and Asset Related Charges - Net, to the interim
Consolidated Financial Statements for additional information on the company's
2021 Restructuring Actions and accelerated prepaid royalty amortization.

Recent Accounting Pronouncements
See Note 2 - Recent Accounting Guidance, to the interim Consolidated Financial
Statements for a description of recent accounting pronouncements.

                                       51

--------------------------------------------------------------------------------

Table of Contents



Segment Reviews
The company operates in two reportable segments: Seed and Crop Protection.

Seed


The company's seed segment is a global leader in developing and supplying
advanced germplasm and traits that produce optimum yield for farms around the
world. The segment is a leader in many of the company's key seed markets,
including North America corn and soybeans, Europe corn and sunflower, as well as
Brazil, India, South Africa and Argentina corn. The segment offers trait
technologies that improve resistance to weather, disease, insects and herbicides
used to control weeds, and trait technologies that enhance food and nutritional
characteristics. In addition, the segment provides digital solutions that assist
farmer decision-making with a view to optimize product selection and,
ultimately, help maximize yield and profitability.

Crop Protection
The crop protection segment serves the global agricultural input industry with
products that protect against weeds, insects and other pests, and disease, and
that improve overall crop health both above and below ground via nitrogen
management and seed-applied technologies. The segment offers crop protection
solutions that provide farmers the tools they need to improve productivity and
profitability, and help keep fields free of weeds, insects and diseases. The
segment is a leader in global herbicides, insecticides, nitrogen stabilizers and
pasture and range management herbicides.

Summarized below are comments on individual segment net sales and segment
operating EBITDA for the three and six months ended June 30, 2021 compared with
the same period in 2020. The company defines segment operating EBITDA as
earnings (i.e., income (loss) from continuing operations before income taxes)
before interest, depreciation, amortization, corporate expenses, non-operating
costs-net, foreign exchange gains (losses), and net unrealized gain or loss from
mark-to-market activity for certain foreign currency derivative instruments that
do not qualify for hedge accounting, excluding the impact of significant items.
Non-operating costs-net consists of non-operating pension and other
post-employment benefit (OPEB) credits, tax indemnification adjustments and
environmental remediation and legal costs associated with legacy EID businesses
and sites. Tax indemnification adjustments relate to changes in indemnification
balances, as a result of the application of the terms of the Tax Matters
Agreement, between Corteva and Dow and/or DuPont that are recorded by the
company as pre-tax income or expense. Beginning January 1, 2021, the company
excludes net unrealized gains or losses from mark-to-market activity for certain
foreign currency derivative instruments that do not qualify for hedge
accounting. See Note 18 - Segment Information, to the interim Consolidated
Financial Statements for details related to significant pre-tax benefits
(charges) excluded from segment operating EBITDA. All references to prices are
based on local price unless otherwise specified.

A reconciliation of segment operating EBITDA to income from continuing operations after income taxes for the three and six months ended June 30, 2021 and 2020 is included in Note 18 - Segment Information, to the interim Consolidated Financial Statements.


                                        Three Months Ended       Six Months Ended
         Seed                                June 30,                June 30,
         In millions                      2021         2020       2021       2020
         Net sales                  $    3,780       $ 3,538   $   6,272   $ 5,993
         Segment operating EBITDA   $    1,123       $   956   $   1,740   $ 1,537


Seed                             Q2 2021 vs. Q2 2020                                      Percent Change Due To:
                                   Net Sales Change             Local Price &                                               Portfolio /
$ In millions                     $                  %           Product Mix          Volume            Currency               Other
North America            $             201               7  %               -  %              6  %                1  %                   -  %
EMEA                                    34              13  %              10  %             (1) %                4  %                   -  %
Latin America                           28              14  %              10  %              -  %                4  %                   -  %
Asia Pacific                           (21)            (13) %               -  %            (16) %                3  %                   -  %
Total                    $             242               7  %               1  %              4  %                2  %                   -  %



                                       52

--------------------------------------------------------------------------------
  Table of Contents
Seed                             Q2 2021 vs. Q2 2020                                     Percent Change Due To:
                                  Net Sales Change             Local Price &                                               Portfolio /
$ In millions                     $                 %           Product Mix          Volume            Currency               Other
Corn                     $             123              6  %               3  %              2  %                1  %                   -  %
Soybeans                                75              7  %              (2) %              8  %                1  %                   -  %
Other oilseeds                          52             24  %               4  %             11  %                9  %                   -  %
Other                                   (8)            (5) %              (5) %             (2) %                2  %                   -  %
Total                    $             242              7  %               1  %              4  %                2  %                   -  %



                           First Half 2021 vs. First Half
Seed                                    2020                                            Percent Change Due To:
                                  Net Sales Change            Local Price &                                               Portfolio /
$ In millions                    $                 %           Product Mix          Volume            Currency               Other
North America            $           121               3  %              (1) %              3  %                1  %                   -  %
EMEA                                 100               9  %               5  %              1  %                3  %                   -  %
Latin America                         86              20  %               9  %             20  %               (9) %                   -  %
Asia Pacific                         (28)            (12) %               2  %            (15) %                1  %                   -  %
Total                    $           279               5  %               1  %              3  %                1  %                   -  %



                           First Half 2021 vs. First Half
Seed                                    2020                                            Percent Change Due To:
                                  Net Sales Change            Local Price &                                               Portfolio /
$ In millions                    $                 %           Product Mix          Volume            Currency               Other
Corn                     $           147               4  %               3  %              1  %                -  %                   -  %
Soybeans                              71               6  %              (2) %              7  %                1  %                   -  %
Other oilseeds                       100              21  %               4  %             14  %                3  %                   -  %
Other                                (39)            (12) %              (5) %             (7) %                -  %                   -  %
Total                    $           279               5  %               1  %              3  %                1  %                   -  %



Seed
Seed net sales were $3,780 million in the second quarter of 2021, up 7 percent
from $3,538 million in the second quarter of 2020. The increase was due to a 4
percent increase in volume, a 2 percent favorable impact from currency and a 1
percent increase in local price.

Higher volumes were driven by more normalized delivery timing in North America
compared to the prior-year period, coupled with increased soybean acreage in
North America. In addition, the company delivered $80 million in sales in the
second quarter primarily due to robust early demand for corn in Latin America.
This increase was also driven by canola growth in Canada, which represents early
settlement of the season compared to the year-ago period. Favorable currency
impacts were primarily driven by the Canadian Dollar. The increase in local
price was led by strong execution in Latin America and EMEA.

Segment operating EBITDA was $1,123 million in the second quarter of 2021, up 17
percent from $956 million in the second quarter of 2020. Volume gains, lower
royalties, reduced bad debt expense, ongoing cost and productivity actions, and
continued price execution more than offset higher input costs from unfavorable
yields on European corn and sunflower. Segment operating EBITDA margin improved
by more than 260 basis points versus the prior-year period.

Seed net sales were $6,272 million for the first six months of 2021, up 5
percent from $5,993 million for the first six months of 2020. The increase was
due to a 3 percent increase in volume, a 1 percent increase in local price and a
1 percent favorable impact from currency.

The increase in volume was driven by higher soybean sales in North America, market share gains in the Brazil Safrinha, earlier shipments in the Brazil summer season, and canola growth in Canada. Local price gains were driven by strong adoption of new seed technology, including price execution in Latin America and EMEA, with corn price up 3 percent globally. These gains were partially offset by competitive pricing pressure in North America soybeans, where price was down 2 percent. Favorable


                                       53

--------------------------------------------------------------------------------

Table of Contents currency impacts primarily from the Canadian Dollar and the Euro more than offset unfavorable impacts from the Brazilian Real.



Segment operating EBITDA was $1,740 million for the first six months of 2021, up
13 percent from $1,537 million for the first six months of 2020. Continued price
execution, lower royalties, lower bad debt expense, volume gains, and ongoing
cost and productivity actions more than offset higher input costs from
unfavorable yields on European corn and sunflower and higher freight costs.
Segment operating EBITDA margin improved by more than 200 basis points versus
the prior-year period.

                                        Three Months Ended       Six Months Ended
         Crop Protection                     June 30,                June 30,
         In millions                      2021         2020       2021       2020
         Net sales                  $    1,847       $ 1,653   $   3,533   $ 3,154
         Segment Operating EBITDA   $      370       $   309   $     691   $   547


Crop Protection                    Q2 2021 vs. Q2 2020                                     Percent Change Due To:
                                    Net Sales Change             Local Price &                                               Portfolio /
$ In millions                       $                 %           Product Mix          Volume            Currency               Other
North America              $              75             11  %               2  %              8  %                1  %                   -  %
EMEA                                      33              9  %               2  %             (2) %                9  %                   -  %
Latin America                             45             15  %               3  %              8  %                4  %                   -  %
Asia Pacific                              41             14  %               3  %              6  %                7  %                  (2) %
Total                      $             194             12  %               3  %              5  %                4  %                   -  %

Crop Protection                    Q2 2021 vs. Q2 2020                                     Percent Change Due To:
                                    Net Sales Change             Local Price &                                               Portfolio /
$ In millions                       $                 %           Product Mix          Volume            Currency               Other
Herbicides                 $              60              7  %               2  %              1  %                4  %                   -  %
Insecticides                              15              3  %               2  %             (3) %                4  %                   -  %
Fungicides                                87             39  %               4  %             28  %                9  %                  (2) %
Other                                     32             43  %               6  %             34  %                3  %                   -  %
Total                      $             194             12  %               3  %              5  %                4  %                   -  %


                            First Half 2021 vs. First Half
Crop Protection                          2020                                            Percent Change Due To:
                                   Net Sales Change            Local Price &                                               Portfolio /
$ In millions                      $                %           Product Mix          Volume            Currency               Other
North America              $           133             12  %               3  %              7  %                2  %                   -  %
EMEA                                   102             11  %               2  %              2  %                7  %                   -  %
Latin America                           71             13  %               9  %              9  %               (5) %                   -  %
Asia Pacific                            73             14  %               3  %              8  %                6  %                  (3) %
Total                      $           379             12  %               4  %              6  %                3  %                  (1) %

                            First Half 2021 vs. First Half
Crop Protection                          2020                                            Percent Change Due To:
                                   Net Sales Change            Local Price &                                               Portfolio /
$ In millions                      $                %           Product Mix          Volume            Currency               Other
Herbicides                 $           223             13  %               4  %              6  %                3  %                   -  %
Insecticides                            22              3  %               5  %             (3) %                1  %                   -  %
Fungicides                             119             26  %               4  %             21  %                4  %                  (3) %
Other                                   15             10  %               3  %              8  %               (1) %                   -  %
Total                      $           379             12  %               4  %              6  %                3  %                  (1) %




                                       54

--------------------------------------------------------------------------------
  Table of Contents
Crop Protection
Crop protection net sales were $1,847 million in the second quarter of 2021, up
12 percent from $1,653 million in the second quarter of 2020. The increase was
due to a 5 percent increase in volume, a 4 percent favorable impact from
currency and a 3 percent increase in local price.

The increase in volume was driven by continued penetration of new products,
including ArylexTM herbicide and PyraxaltTM insecticide, coupled by early demand
in Latin America, which shifted approximately $50 million in sales from the
third quarter. These volume gains were partially offset by an approximate $60
million impact from our decision to phase out select low-margin products.
Favorable currency impacts were primarily from the Euro. The increase in local
price was driven by strategic price increases in North America, coupled with
strong price execution globally.

Segment operating EBITDA was $370 million in the second quarter of 2021, up 20
percent from $309 million in the second quarter of 2020. Volume gains from new
products, continued pricing execution, productivity, and favorable impacts from
currency more than offset higher input costs, including raw material costs.
Segment operating EBITDA margin improved by more than 130 basis points versus
the prior-year period.

Crop protection net sales were $3,533 million for the first six months of 2021,
up 12 percent from $3,154 million for the first six months of 2020. The increase
was due to a 6 percent increase in volume, a 4 percent increase in local price
and a 3 percent favorable impact from currency, partially offset by a 1 percent
unfavorable portfolio impact.

Volume gains were led by continued penetration of new products, including
ArylexTM and EnlistTM herbicides and Pyraxalt™ insecticide. These volume gains
were partially offset by an approximate $130 million impact from our decision to
phase out select low-margin products. The increase in local price was primarily
driven by gains in Latin America and North America. Favorable currency impacts
primarily from the Euro more than offset unfavorable impacts from the Brazilian
Real. The portfolio impact was driven by prior-year divestitures in Asia
Pacific.

Segment operating EBITDA was $691 million for the first six months of 2021, up
26 percent from $547 million for the first six months of 2020. Favorable mix,
continued penetration of new products, and ongoing cost and productivity actions
more than offset higher input costs, including raw material costs. Segment
operating EBITDA margin improved by more than 220 basis points versus the
prior-year period.

                                       55

--------------------------------------------------------------------------------

Table of Contents



Non-GAAP Financial Measures
The company presents certain financial measures that do not conform to U.S. GAAP
and are considered non-GAAP measures. These measures include Operating EBITDA
and operating earnings per share. Management uses these measures internally for
planning and forecasting, including allocating resources and evaluating
incentive compensation. Management believes that these non-GAAP measures best
reflect the ongoing performance of the company during the periods presented and
provide more relevant and meaningful information to investors as they provide
insight with respect to ongoing operating results of the company and a more
useful comparison of year over year results. These non-GAAP measures supplement
the company's U.S. GAAP disclosures and should not be viewed as an alternative
to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may
not be consistent with similar measures provided or used by other companies.
Reconciliations for these non-GAAP measures to U.S. GAAP are provided below.

Operating EBITDA is defined as earnings (i.e., income (loss) from continuing
operations before income taxes) before interest, depreciation, amortization,
non-operating (benefits) costs - net, foreign exchange gains (losses), and net
unrealized gain or loss from mark-to-market activity for certain foreign
currency derivative instruments that do not qualify for hedge accounting,
excluding the impact of significant items. Non-operating (benefits) costs - net
consists of non-operating pension and OPEB credits, tax indemnification
adjustments and environmental remediation and legal costs associated with legacy
businesses and sites of Historical DuPont. Tax indemnification adjustments
relate to changes in indemnification balances, as a result of the application of
the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont
that are recorded by the company as pre-tax income or expense. Operating
earnings per share is defined as "Earnings per common share from continuing
operations - diluted" excluding the after-tax impact of significant items, the
after-tax impact of non-operating (benefits) costs - net, the after-tax impact
of amortization expense associated with intangible assets existing as of the
Separation from DowDuPont, and the after-tax impact of net unrealized gain or
loss from mark-to-market activity for certain foreign currency derivative
instruments that do not qualify for hedge accounting. Although amortization of
the company's intangible assets is excluded from these non-GAAP measures,
management believes it is important for investors to understand that such
intangible assets contribute to revenue generation. Amortization of intangible
assets that relate to past acquisitions will recur in future periods until such
intangible assets have been fully amortized. Any future acquisitions may result
in amortization of additional intangible assets. Net unrealized gain or loss
from mark-to-market activity for certain foreign currency derivative instruments
that do not qualify for hedge accounting represents the non-cash net gain (loss)
from changes in fair value of certain undesignated foreign currency derivative
contracts. Upon settlement, which is within the same calendar year of execution
of the contract, the realized gain (loss) from the changes in fair value of the
non-qualified foreign currency derivative contracts will be reported in the
relevant non-GAAP financial measures, allowing quarterly results to reflect the
economic effects of the foreign currency derivative contracts without the
resulting unrealized mark to fair value volatility.

Reconciliation of Income from Continuing Operations after Income Taxes to Operating EBITDA


                                                          Three Months Ended            Six Months Ended
                                                               June 30,                     June 30,
(In millions)                                              2021           2020         2021          2020

Income from continuing operations after income taxes (GAAP)

$    1,018       $     766    $    1,631    $   1,047
Provision for income taxes on continuing operations         284              78           462          205
Income from continuing operations before income
taxes (GAAP)                                              1,302             844         2,093        1,252
Depreciation and amortization                               313             300           617          583
Interest income                                             (18)             (9)          (39)         (27)
Interest expense                                              7              14            14           24
Exchange losses (gains) - net                                14              (1)           49           60
Non-operating benefits - net                               (315)            

(91) (626) (164)



Mark-to-market losses on certain foreign currency
contracts not designated as hedges1                          23                            22
Significant items charge                                    135             179           235          302

Operating EBITDA (Non-GAAP)                          $    1,461       $   

1,236 $ 2,365 $ 2,030




1.Effective January 1, 2021, on a prospective basis, the company excludes net
unrealized gain or loss from mark-to-market activity for certain foreign
currency derivative instruments that do not qualify for hedge accounting. For
the three and six months ended June 30, 2020, the unrealized mark-to-market gain
was $27 million.


                                       56

--------------------------------------------------------------------------------
  Table of Contents
Significant Items
                                                         Three Months Ended              Six Months Ended
                                                              June 30,                       June 30,
(In millions)                                             2021            2020           2021           2020

Restructuring and asset related charges - net $ (135) $ (179) $ (235) $ (249) Loss on divestiture

                                         -                 -             -             (53)
Total pretax significant items charge                    (135)             (179)         (235)           (302)
Total tax benefit impact of significant items1             28                36            51              59
Tax only significant item benefit2                          -                29             -              10

Total significant items charge, after tax $ (107) $ (114) $ (184) $ (233)




1.Unless specifically addressed above, the income tax effect on significant
items was calculated based upon the enacted tax laws and statutory income tax
rates applicable in the tax jurisdiction(s) of the underlying non-GAAP
adjustment.
2.The tax only significant item benefits for the three and six months ended June
30, 2020 are primarily related to a benefit due to an elective change in
accounting method that alters the 2019 impact of the business separation on The
Act's foreign tax provisions and a state tax valuation allowance in the U.S.
based on a change in judgment about the realizability of a deferred tax asset.

Reconciliation of Income from Continuing Operations Attributable to Corteva and Earnings Per Share of Common Stock from Continuing Operations - Diluted to Operating Earnings and Operating Earnings Per Share


                                                              Three Months Ended            Six Months Ended
                                                                   June 30,                     June 30,
(In millions)                                                  2021            2020         2021        2020

Income from continuing operations attributable to
Corteva (GAAP)                                          $     1,015         $    760    $   1,625    $  1,031
Less: Non-operating benefits - net, after tax                   237               67          474         124
Less: Amortization of intangibles (existing as of
Separation), after tax                                         (140)        

(137) (283) (251)

Less: Mark-to-market losses on certain foreign currency contracts not designated as hedges, after tax1

                  (18)                          (17)
Less: Significant items charge, after tax                      (107)            (114)        (184)       (233)
Operating Earnings (Non-GAAP)                           $     1,043         $    944    $   1,635    $  1,391


                                                              Three Months Ended            Six Months Ended
                                                                   June 30,                     June 30,
                                                               2021           2020          2021          2020

Earnings per share of common stock from continuing operations - diluted (GAAP)

$     1.37         $   1.01    $    2.18       $   1.37
Less: Non-operating benefits - net, after tax                 0.32             0.09         0.64           0.16
Less: Amortization of intangibles (existing as of
Separation), after tax                                       (0.19)         

(0.19) (0.38) (0.33)

Less: Mark-to-market losses on certain foreign currency contracts not designated as hedges, after tax1

               (0.02)                        (0.02)
Less: Significant items charge, after tax                    (0.14)           (0.15)       (0.25)         (0.31)
Operating Earnings Per Share (Non-GAAP)                 $     1.40         $   1.26    $    2.19       $   1.85
Diluted Shares Outstanding (in millions)                     743.3          

751.6 746.4 752.0




1.Effective January 1, 2021, on a prospective basis, the company excludes net
unrealized gain or loss from mark-to-market activity for certain foreign
currency derivative instruments that do not qualify for hedge accounting. For
the three and six months ended June 30, 2020, the unrealized mark-to-market gain
was $27 million.

                                       57
--------------------------------------------------------------------------------
  Table of Contents
Liquidity and Capital Resources
Information related to the company's liquidity and capital resources can be
found in the company's 2020 Annual Report, Part II, Item 7. Management's
Discussion and Analysis of Financial Condition and Results of Operations,
Liquidity & Capital Resources. The discussion below provides the updates to this
information for the six months ended June 30, 2021.
(In millions)                                 June 30, 2021      December 31, 2020     June 30, 2020
Cash, cash equivalents and marketable
securities                                  $         2,900    $            3,795    $         2,869
Total debt                                  $         1,778    $            1,105    $         2,631



The company's cash, cash equivalents and marketable securities at June 30, 2021,
December 31, 2020, and June 30, 2020 were $2,900 million, $3,795 million and
$2,869 million, respectively. Total debt at June 30, 2021, December 31, 2020,
and June 30, 2020 was $1,778 million, $1,105 million, and $2,631 million,
respectively. The increase in debt balances from December 31, 2020 was primarily
due to funding the company's seasonal working capital needs and capital
expenditures. See further information in Note 12 - Short-Term Borrowings,
Long-Term Debt and Available Credit Facilities, to the interim Consolidated
Financial Statements.

The company believes its ability to generate cash from operations and access to
capital markets and commercial paper markets will be adequate to meet
anticipated cash requirements to fund its operations, including seasonal working
capital, capital spending, funding of the MOU escrow account, and pension
obligations. Corteva's strong financial position, liquidity and credit ratings
will provide access as needed to capital markets and commercial paper markets to
fund seasonal working capital needs. The company's liquidity needs can be met
through a variety of sources, including cash provided by operating activities,
commercial paper, syndicated credit lines, bilateral credit lines, long-term
debt markets, bank financing and committed receivable repurchase facilities.
Corteva considers the borrowing costs and lending terms when selecting the
source to fund its operations and working capital needs. During the six months
ended June 30, 2021, the company has experienced increased operating costs for
freight and raw materials. The company also has experienced increased costs for
materials used in various capital expenditures and capacity expansion projects.
The increases in costs have been due, in part to, inflation and the rising
demand from the economic recovery from the lifting of COVID-19 pandemic
restrictions and government stimulus in some regions, while the supply for
certain materials have not returned to pre-pandemic levels. The company expects
this trend to continue as global supply chains and logistics remain constrained
across industries.

The company had access to approximately $6.4 billion at June 30, 2021, $6.4
billion at December 31, 2020, and $6.3 billion at June 30, 2020, in committed
and uncommitted unused credit lines. In addition to the unused credit
facilities, the company has a $1 billion 2021 Repurchase Facility (as defined
below). These facilities provide support to meet the company's short-term
liquidity needs and for general corporate purposes which may include funding of
discretionary and nondiscretionary contributions to certain benefit plans,
severance payments, repayment and refinancing of debt, working capital, capital
expenditures, repurchases and redemptions of securities, and funding Corteva's
costs and expenses.

In March 2020, the company drew down $500 million under the three year revolving
credit facility to finance its short term liquidity needs as a result of the
volatility and increased borrowing costs of commercial paper resulting from the
unstable market conditions caused by the COVID-19 pandemic, and repaid that
borrowing in full in June 2020. The Revolving Credit Facilities contain
customary representations and warranties, affirmative and negative covenants and
events of default that are typical for companies with similar credit ratings.
The Revolving Credit Facilities also contain a financial covenant requiring that
the ratio of total indebtedness to total capitalization for Corteva and its
consolidated subsidiaries not exceed 0.60. At June 30, 2021 the company was in
compliance with these covenants.

In May 2020, EID issued $500 million of 1.70 percent Senior Notes due 2025 and
$500 million of 2.30 percent Senior Notes due 2030 (the May 2020 Debt Offering).
The proceeds of this offering are intended to be used for general corporate
purposes.

The company's indenture covenants include customary limitations on liens, sale
and leaseback transactions, and mergers and consolidations affecting
manufacturing plants, mineral producing properties or research facilities
located in the U.S. and the consolidated subsidiaries owning such plants,
properties and facilities subject to certain limitations. The outstanding
long-term debt also contains customary default provisions.
The company has meaningful seasonal working capital needs based in part on
providing financing to its customers. Working capital is funded through multiple
methods including cash, commercial paper, the 2021 Repurchase Facility, the
Revolving Credit Facilities, and factoring.

                                       58
--------------------------------------------------------------------------------
  Table of Contents
In February 2021, in line with seasonal working capital requirements, the
company entered into a committed receivable repurchase agreement of up to $1.0
billion (the "2021 Repurchase Facility"), which expires in December 2021. Under
the 2021 Repurchase Facility, Corteva may sell a portfolio of available and
eligible outstanding customer notes receivables to participating institutions
and simultaneously agree to repurchase at a future date. See further discussion
of this facility in Note 12 - Short-Term Borrowings, Long-Term Debt and
Available Credit Facilities, to the interim Consolidated Financial Statements.

The company has factoring agreements with third-party financial institutions to
sell its trade receivables under both recourse and non-recourse agreements in
exchange for cash proceeds in an effort to reduce its receivables risk. For
arrangements that include an element of recourse, the company provides a
guarantee of the trade receivables in the event of customer default. Refer to
Note 9 - Accounts and Notes Receivable - Net, to the interim Consolidated
Financial Statements for more information.
The company also organizes agreements with third-party financial institutions
who directly provide financing for select customers of the company's seed and
crop protection products in each region. Terms of the third-party loans are less
than a year and programs are renewed on an annual basis. In some cases, the
company guarantees a portion of the extension of such credit to such customers.
Refer to Note 13 - Commitments and Contingent Liabilities, to the interim
Consolidated Financial Statements for more information on the company's
guarantees.

The company's cash, cash equivalents and marketable securities at June 30, 2021,
December 31, 2020, and June 30, 2020 are $2.9 billion, $3.8 billion, and $2.9
billion respectively, of which $2.7 billion, $3.1 billion, and $2.7 billion at
June 30, 2021, December 31, 2020, and June 30, 2020, respectively, was held by
subsidiaries in foreign countries, including United States territories. The 2017
Tax Cuts and Jobs Act ("The Act") required companies to pay a one-time
transition tax on the untaxed earnings of foreign subsidiaries. Upon actual
repatriation, such earnings could be subject to withholding taxes, foreign
and/or U.S. state income taxes, and taxes resulting from the impact of foreign
currency movements. The Act also introduced a 100 percent dividends received
deduction regarding earnings of foreign subsidiaries. The cash held by foreign
subsidiaries is generally used to finance the subsidiaries' operational
activities and future foreign investments. At June 30, 2021, management believed
that sufficient liquidity is available in the U.S. with global operating cash
flows, borrowing capacity from existing committed credit facilities, and access
to capital markets and commercial paper markets.

Summary of Cash Flows
Cash used for operating activities was $643 million for the six months ended
June 30, 2021 compared to $869 million for the six months ended June 30, 2020.
The change in cash used for operating activities was driven by higher earnings
partially offset by changes in working capital.

Cash used for investing activities was $17 million for the six months ended June
30, 2021 compared to $252 million for the six months ended June 30, 2020. The
change was primarily due to lower purchases of investments, partly offset by
higher capital expenditures. The company is increasing its expected 2021 capital
expenditures to $600 - $650 million, which is primarily driven by increases in
costs for materials used in various capital expenditures and capacity expansion
projects.

Cash (used for) provided by financing activities was $(27) million for the six
months ended June 30, 2021 compared to $2.2 billion for the six months ended
June 30, 2020. The change was primarily due to lower borrowings partially offset
by higher repurchases of Corteva common stock.

In January 2021, the company's Board of Directors authorized a common stock
dividend of $0.13 per share, payable on March 15, 2021, to the shareholders of
record on March 1, 2021. In April 2021, the company's Board of Directors
authorized a common stock dividend of $0.13 per share, payable on June 15, 2021,
to the shareholders of record on May 14, 2021. In July 2021, the company's Board
of Directors approved an increase in the common stock dividend of $0.13 per
share to $0.14 per share. In July 2021, the company's Board of Directors
authorized a common stock dividend of $0.14 per share, payable on September 15,
2021, to the shareholders of record on August 13, 2021.

On August 5, 2021, the company's Board of Directors authorized a $1.5 billion
share repurchase program to purchase Corteva, Inc.'s common stock, par value
$0.01 per share, without an expiration date.

On June 26, 2019, the company's Board of Directors authorized a $1 billion share
repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per
share, without an expiration date. The company repurchased $850 million under
its share buyback plan since the Corteva Distribution and expects to complete
the program in 2021.

For the full year 2021, the company expects to repurchase at least $850 million
under the share buyback plans discussed above. The total amount, timing, price
and volume of purchases will be based on market conditions, relevant securities
laws and other market and company specific factors.
                                       59

--------------------------------------------------------------------------------

Table of Contents



During the three and six months ended June 30, 2021, the company purchased and
retired 4,324,000 shares and 11,970,000 shares, respectively, in the open market
for a total cost of $200 million and $550 million, respectively. During the six
months ended June 30, 2020, the company purchased and retired 1,865,000 shares
for a total cost of $50 million. See Note 14 - Stockholders' Equity, to the
interim Consolidated Financial Statements for additional information related to
the share buyback plan.

EID Liquidity Discussion
As discussed in Note 1 - Basis of Presentation, to the EID interim Consolidated
Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a
reporting company, subject to the requirements of the Exchange Act. The below
relates to EID only and is presented to provide a Liquidity discussion for the
differences between EID and Corteva, Inc.

Cash used for operating activities
EID's cash used for operating activities was $663 million and $920 million for
the six months ended June 30, 2021 and 2020, respectively. The change was
primarily driven by the items above under the header, "Summary of Cash Flow".

Cash provided by financing activities
EID's cash (used for) provided by financing activities was $(7) million for the
six months ended June 30, 2021 compared to $2,265 million for the six months
ended June 30, 2020. The change was primarily driven by lower proceeds from
issuance of long-term debt and higher payments on long-term debt on related
party debt.

See Note 2 - Related Party Transactions, to the EID interim Consolidated Financial Statements for further information on the related party loan between EID and Corteva, Inc.



Guarantees and Off-Balance Sheet Arrangements
For detailed information related to Guarantees, Indemnifications, and
Obligations for Equity Affiliates and Others, see the company's 2020 Annual
Report, Part II, Item 7. Management's Discussion and Analysis of Financial
Condition and Results of Operations, Off-Balance Sheet Arrangements and Note 13
- Commitments and Contingent Liabilities, to the interim Consolidated Financial
Statements.

Contractual Obligations

Information related to the company's contractual obligations at December 31,
2020 can be found on page 73 of the company's 2020 Annual Report. There have
been no material changes to the company's contractual obligations outside the
ordinary course of business from those reported in the company's 2020 Annual
Report.

© Edgar Online, source Glimpses